BBY
36
-2
ETR
61
-2
DD
36
-4
MAT
50
-5
PBI
38
-2
REGN
32
-4
RF
70
3
A
41
-2
XOM
62
2
WHR
47
-3
MSI
50
-5
CRM
42
2
AEP
69
-3
MUR
44
2
JNJ
50
-3
PCAR
33
2
NWSA
73
2
TDC
26
-4
WAT
43
-5
BA
47
2
BBY
36
-2
ETR
61
-2
DD
36
-4
MAT
50
-5
PBI
38
-2
REGN
32
-4
RF
70
3
A
41
-2
XOM
62
2
WHR
47
-3
MSI
50
-5
CRM
42
2
AEP
69
-3
MUR
44
2
JNJ
50
-3
PCAR
33
2
NWSA
73
2
TDC
26
-4
WAT
43
-5
BA
47
2
Financhill
Back

Novo Nordisk AS Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13

NVO
Novo Nordisk AS

Last Price:
$71.73
Seasonality Move:
4.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

Novo Nordisk AS Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 77.73 Sell
20-day SMA: 82.1 Sell
50-day SMA: 83.19 Sell
200-day SMA: 112.07 Sell
8-day EMA: 77.22 Sell
20-day EMA: 80.23 Sell
50-day EMA: 84.71 Sell
200-day EMA: 102.11 Sell

Novo Nordisk AS Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.74 Sell
Relative Strength Index (14 RSI): 34.25 Sell
Chaikin Money Flow: -6327094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.23 - 89.07) Sell
Bollinger Bands (100): (80.52 - 104.68) Sell

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Novo Nordisk AS Stock

Is Novo Nordisk AS Stock a Buy?

  • Novo Nordisk AS share price is 73.60 while NVO 8-day simple moving average is 77.73, which is a Sell signal.
  • The stock price of NVO is 73.60 while Novo Nordisk AS 20-day SMA is 82.10, which makes it a Sell.
  • Novo Nordisk AS 50-day simple moving average is 83.19 while NVO share price is 73.60, making it a Sell technically.
  • NVO stock price is 73.60 and Novo Nordisk AS 200-day simple moving average is 112.07, creating a Sell signal.

NVO Technical Analysis vs Fundamental Analysis

Sell
13
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy or a Sell?

  • Novo Nordisk AS stock is rated a Sell
    The current Novo Nordisk AS [NVO] share price is $73.60. The Score for NVO is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.

Novo Nordisk AS Stock Info

Market Cap:
326.7B
Price in USD:
73.60
Share Volume:
8.8M

Novo Nordisk AS 52-Week Range

52-Week High:
148.15
52-Week Low:
73.20
Sell
13
Novo Nordisk AS (NVO) is a Sell

Novo Nordisk AS Share Price Forecast

Is Novo Nordisk AS Stock a Buy?

  • Novo Nordisk AS share price is 73.60 while NVO 8-day exponential moving average is 77.22, which is a Sell signal.
  • The stock price of NVO is 73.60 while Novo Nordisk AS 20-day EMA is 80.23, which makes it a Sell.
  • Novo Nordisk AS 50-day exponential moving average is 84.71 while NVO share price is 73.60, making it a Sell technically.
  • NVO stock price is 73.60 and Novo Nordisk AS 200-day simple moving average is 102.11, creating a Sell signal.

Fundamental Analysis of Novo Nordisk AS

Is Novo Nordisk AS a good investment?

  • Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.07 per share, an increase this year of $0.90 per share, and an increase next year of $0.88 per share.

Technical Analysis of Novo Nordisk AS

Should I short Novo Nordisk AS stock?

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.